Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways

被引:160
作者
Han, SW
Khuri, FR
Roman, J
机构
[1] Emory Univ, Sch Med, Div Pulm Allergy & Crit Care Med, Dept Med, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Dept Hematol & Oncol, Winship Canc Inst, Atlanta, GA 30322 USA
[3] Atlanta Vet Affairs Med Ctr, Atlanta, GA USA
关键词
D O I
10.1158/0008-5472.CAN-05-2367
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Akt/mammalian target of rapamycin (mTOR)/ribosomal protein S6 kinase (p70S6K) pathway is considered a central regulator of protein synthesis and of cell proliferation, differentiation, and survival. However, the role of the Akt/mTOR/ p70S6K pathway in lung carcinoma remains unknown. We previously showed that fibronectin, a matrix glycoprotein highly expressed in tobacco-related lung disease, stimulates non-small cell lung carcinoma (NSCLC) cell growth and survival. Herein, we explore the role of the Akt/mTOR/p70S6K pathway in fibronectin-induced NSCLC cell growth. We found that fibronectin stimulated the phosphorylation of Akt, an upstream inducer of mTOR, and induced the phosphorylation of p70S6K1 and eukaryotic initiation factor 4E-binding protein 1 (4E-BP1), two downstream targets of mTOR in NSCLC cells (111792 and 111838), whereas it inhibited the phosphatase and tensin homologue deleted on chromosome 10, a tumor suppressor protein that antagonizes the phosphatidylinositol 3-kinase/Akt signal. In addition, treatment with fibronectin inhibited the mRNA and protein expression of LKB1 as well as the phosphorylation of AMP-activated protein kinase (AMPK alpha), both known to down-regulate mTOR. Rapamycin, tin inhibitor of mTOR, blocked the fibronectin-induced phosphorylation of p70S6K and 4E-BP1. Akt small interfering RNA (siRNA) and an antibody against the fibronectin-binding integrin alpha(5)beta(1) also blocked the p70S6K phosphorylation in response to fibronectin. In contrast, an inhibitor of extracellular signal-regulated kinase 1/2 (PD98095) had no effect on fibronectin-induced phosphorylation of p70S61L Moreover, the combination of rapamycin and siRNA for Akt blocked fibronectin-induced cell proliferation. Taken together, these observations suggest that fibronectin-induced stimulation of NSCLC cell proliferation requires activation of the Akt/mTOR/p70S6K pathway and is associated with inhibition of LKB1/AMPK signaling.
引用
收藏
页码:315 / 323
页数:9
相关论文
共 45 条
[1]   Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells [J].
Avdulov, S ;
Li, S ;
Michalek, V ;
Burrichter, D ;
Peterson, M ;
Perlman, DM ;
Manivel, JC ;
Sonenberg, N ;
Yee, D ;
Bitterman, PB ;
Polunovsky, VA .
CANCER CELL, 2004, 5 (06) :553-563
[2]   Extracellular matrix-dependent myosin dynamics during G1-S phase cell cycle progression in hepatocytes [J].
Bhadriraju, K ;
Hansen, LK .
EXPERIMENTAL CELL RESEARCH, 2004, 300 (02) :259-271
[3]   New targets for therapy in breast cancer - Mammalian target of rapamycin (mTOR) antagonists [J].
Carraway, H ;
Hidalgo, M .
BREAST CANCER RESEARCH, 2004, 6 (05) :219-224
[4]   Novel and natural knockout lung cancer cell lines for the LKB1/STK11 tumor suppressor gene [J].
Carretero, J ;
Medina, PP ;
Pio, R ;
Montuenga, LM ;
Sanchez-Cespedes, M .
ONCOGENE, 2004, 23 (22) :4037-4040
[5]   Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer [J].
Chan, S .
BRITISH JOURNAL OF CANCER, 2004, 91 (08) :1420-1424
[6]   PD98059 and U0126 activate AMP-activated protein kinase by increasing the cellular AMP:ATP ratio and not via inhibition of the MAP kinase pathway [J].
Dokladda, K ;
Green, KA ;
Pan, DA ;
Hardie, DG .
FEBS LETTERS, 2005, 579 (01) :236-240
[7]   Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression [J].
Fingar, DC ;
Blenis, J .
ONCOGENE, 2004, 23 (18) :3151-3171
[8]   AKT involvement in cisplatin chemoresistance of human uterine cancer cells [J].
Gagnon, V ;
Mathieu, I ;
Sexton, É ;
Leblanc, K ;
Asselin, E .
GYNECOLOGIC ONCOLOGY, 2004, 94 (03) :785-795
[9]   Immunohistochemical expression of integrins and extracellular matrix proteins in non-small cell lung cancer: correlation with lymph node metastasis [J].
Han, JY ;
Kim, HS ;
Lee, SH ;
Park, WS ;
Lee, JY ;
Yoo, NJ .
LUNG CANCER, 2003, 41 (01) :65-70
[10]   Fibronectin stimulates human lung carcinoma cell proliferation by suppressing p21 gene expression via signals involving Erk and Rho kinase [J].
Han, SW ;
Sidell, N ;
Roman, J .
CANCER LETTERS, 2005, 219 (01) :71-81